VOICE Trial
The VOICE Trial is a clinical initiative by Neuralink focused on restoring communication capabilities for patients with severe paralysis through Brain-Computer Interface (BCI) technology. The trial aims to decode neural signals associated with speech intent to enable real-time text generation or synthetic voice output.
Overview
- Objective: Restore functional communication for individuals with locked-in syndrome or similar motor impairments.
- Technology: Utilizes high-bandwidth Neural Link implants to capture neural data from speech-related cortical areas.
- Status: Active development and patient integration as of 2026.
Recent Developments (May 2026)
- Patient Progress: Significant advancements reported in patient care and device stability.
- Trial Milestones: New data points released regarding decoding accuracy and latency improvements.
- Integration: Part of broader BCI milestones highlighting sophisticated signal processing algorithms.
- Source: Neuralink May 2026 Update: Patient Progress, VOICE Trial, and BCI Milestones
Related Concepts
- Neuralink
- brain-computer-interface
- Speech Decoding